FASN and neoplasm: Given the important involvement of the enzyme FASN in numerous tumor types, a number of inhibitors have been designed and/or tested in diverse cancer models: cerulenin, C75, C93, epigallocatechin gallate (EGCG), G28UCM, orlistat, GSK2194069 and GSK837149A.